MedTrace Logo

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

NCT00588068 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2070

Last updated 2025-10-15

No results posted yet for this study

Summary

The purpose of this study is to find out the genetic and biochemical makeup of your neuroblastic tumor, which influences its aggressiveness and the suitable therapy. These research studies include surface marker analysis, cytogenetics, cancer genes,genome sequencing, tumor growth-related genes and tumor growth in test tubes. Your blood, marrow, and hematopoietic stem cell samples will also be tested for tumors or leukemia cells, and your serum tested for anti-tumor antibodies.

Conditions

Interventions

OTHER

Tumor and Marrow Markers

Tumor and Marrow Markers

Sponsors & Collaborators

Principal Investigators

  • Nai-Kong Cheung, M.D., Ph.D. · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-26
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00588068 on ClinicalTrials.gov